GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108. A total of 92 filers reported holding GALENA BIOPHARMA INC in Q1 2014. The put-call ratio across all filers is 0.36 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $455,000 | -22.4% | 1,301,165 | +3.4% | 0.00% | – |
| Q2 2016 | $586,000 | -64.9% | 1,258,625 | +2.5% | 0.00% | -100.0% |
| Q1 2016 | $1,669,000 | +2.9% | 1,227,715 | +11.2% | 0.00% | 0.0% |
| Q4 2015 | $1,622,000 | -6.2% | 1,103,979 | +0.9% | 0.00% | 0.0% |
| Q3 2015 | $1,729,000 | -6.3% | 1,094,592 | +0.8% | 0.00% | 0.0% |
| Q2 2015 | $1,846,000 | +57.2% | 1,086,133 | +28.5% | 0.00% | 0.0% |
| Q1 2015 | $1,174,000 | +10.4% | 845,146 | +20.0% | 0.00% | 0.0% |
| Q4 2014 | $1,063,000 | -26.8% | 704,579 | -0.1% | 0.00% | 0.0% |
| Q3 2014 | $1,453,000 | -31.9% | 705,465 | +1.1% | 0.00% | 0.0% |
| Q2 2014 | $2,135,000 | +46.7% | 697,955 | +19.9% | 0.00% | 0.0% |
| Q1 2014 | $1,455,000 | -40.0% | 582,268 | +19.0% | 0.00% | -50.0% |
| Q4 2013 | $2,426,000 | +146.3% | 489,295 | +12.8% | 0.00% | +100.0% |
| Q3 2013 | $985,000 | +33.1% | 433,721 | +30.0% | 0.00% | 0.0% |
| Q2 2013 | $740,000 | – | 333,521 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 5,446,469 | $13,616,000 | 2.03% |
| Harbour Capital Advisors, LLC | 78,450 | $196,000 | 0.19% |
| SABBY MANAGEMENT, LLC | 708,089 | $1,770,000 | 0.10% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 174,600 | $437,000 | 0.07% |
| Alyeska Investment Group, L.P. | 530,000 | $1,950,000 | 0.05% |
| HIGHLAND CAPITAL MANAGEMENT LP | 528,027 | $1,320,000 | 0.05% |
| KMS FINANCIAL SERVICES, INC | 118,042 | $295,000 | 0.05% |
| Quantitative Investment Management, LLC | 348,500 | $871,000 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 538,100 | $1,345,000 | 0.04% |
| DUMONT & BLAKE INVESTMENT ADVISORS LLC | 29,675 | $74,000 | 0.04% |